BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation. - Li, Yang-Ling; Rao, Ming-Jun; Zhang, Ning-Yu; Wu, Lin-Wen; Lin, Neng-Ming; Zhang, Chong (Experimental & Therapeutic Medicine, 2019)